These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21224014)

  • 1. The therapeutic potential of the targeted autoreactive B lymphocytes by rituximab in SLE.
    Wang C; Pan HF; Ye DQ
    Autoimmun Rev; 2012 Mar; 11(5):373. PubMed ID: 21224014
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective silencing of autoreactive B lymphocytes-Following the Nature's way.
    Nikolova KA; Mihaylova NM; Voynova EN; Tchorbanov AI; Voll RE; Vassilev TL
    Autoimmun Rev; 2010 Sep; 9(11):775-9. PubMed ID: 20601201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting B cells in treatment of autoimmunity.
    Franks SE; Getahun A; Hogarth PM; Cambier JC
    Curr Opin Immunol; 2016 Dec; 43():39-45. PubMed ID: 27718447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic potential of bispecific antibodies.
    van de Winkel JG; Bast B; de Gast GC
    Immunol Today; 1997 Dec; 18(12):562-4. PubMed ID: 9425731
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating human autoimmune disease by depleting B cells.
    Looney RJ
    Ann Rheum Dis; 2002 Oct; 61(10):863-6. PubMed ID: 12228152
    [No Abstract]   [Full Text] [Related]  

  • 6. B Cell Modulation Strategies in Autoimmune Diseases: New Concepts.
    Musette P; Bouaziz JD
    Front Immunol; 2018; 9():622. PubMed ID: 29706952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell immunotherapy in autoimmunity--2010 update.
    Chan AC
    Mol Immunol; 2011 Jun; 48(11):1344-7. PubMed ID: 21194752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotype manipulation for autoimmune diseases: where are we going?
    Zouali M; Isenberg DA; Morrow WJ
    Autoimmunity; 1996; 24(1):55-63. PubMed ID: 8937688
    [No Abstract]   [Full Text] [Related]  

  • 9. B cell targeted therapies in autoimmune disease.
    Barnas JL; Looney RJ; Anolik JH
    Curr Opin Immunol; 2019 Dec; 61():92-99. PubMed ID: 31733607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocrelizumab: a step forward in the evolution of B-cell therapy.
    Kausar F; Mustafa K; Sweis G; Sawaqed R; Alawneh K; Salloum R; Badaracco M; Niewold TB; Sweiss NJ
    Expert Opin Biol Ther; 2009 Jul; 9(7):889-95. PubMed ID: 19463076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell depletion in autoimmune diseases. Advances in autoimmunity.
    Guzman Moreno R
    Autoimmun Rev; 2009 Jun; 8(7):585-90. PubMed ID: 19393204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.
    Derby L; Czuczman MS
    Future Oncol; 2011 Aug; 7(8):963-79. PubMed ID: 21823892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell immunobiology in disease: evolving concepts from the clinic.
    Martin F; Chan AC
    Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis.
    Tuscano JM; Martin S; Song K; Wun T
    Hematology; 2005 Dec; 10(6):521-7. PubMed ID: 16321818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bispecific single-chain antibody fusion protein for targeted depletion of autoreactive B cells via unstimulated human T lymphocytes.
    Zocher M; Baeuerle PA
    Mol Immunol; 2004 Jul; 41(5):511-8. PubMed ID: 15183929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP
    J Neuroimmunol; 2008 Nov; 204(1-2):1-12. PubMed ID: 18783837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies in adult acute lymphoblastic leukemia.
    Kantarjian H
    Hematology; 2012 Apr; 17 Suppl 1():S52-4. PubMed ID: 22507779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell depletion in autoimmune rheumatic diseases.
    Pitashny M; Shoenfeld Y
    Autoimmun Rev; 2005 Sep; 4(7):436-41. PubMed ID: 16137609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.